Gene · 7025
Papers1,849
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,849
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effective treatment of NR2F1-related epilepsy with perampanel. | Acta Epileptol | 2024 | 40217317 | PubTator, text mining | PubMed |
| [DNA Methylation Profiling in Aneurysm and Comorbid Atherosclerosis of the Ascending Aorta]. | Mol Biol (Mosk) | 2024 | 39707852 | PubTator, text mining | PubMed |
Detection of chromosome 5q interstitial deletion of 5q14.3-q31.1 by chromosome microarray analysis in a second-trimester fetus with multiple congenital anomalies and a literature review of chromosome 5q interstitial deletion syndrome. | Taiwan J Obstet Gynecol | 2024 | 39482004 | PubTator, text mining | PubMed |
| Retraction: NR2F1-AS1/miR-190a/PHLDB2 induces the epithelial-mesenchymal transformation process in gastric cancer by promoting phosphorylation of AKT3. | Front Cell Dev Biol | 2024 | 39324069 | PubTator, text mining | PubMed |
| Roles of the NR2F Family in the Development, Disease, and Cancer of the Lung. | J Dev Biol | 2024 | 39311119 | PubTator, text mining | PubMed |
| Single-cell landscape of intratumoral heterogeneity and tumor microenvironment remolding in pre-nodal metastases of breast cancer. | J Transl Med | 2024 | 39210391 | PubTator, text mining | PubMed |
| Elevated GRHL2 Imparts Plasticity in ER-Positive Breast Cancer Cells. | Cancers (Basel) | 2024 | 39199676 | PubTator, text mining | PubMed |
| Bioinformatics analysis to disclose shared molecular mechanisms between type-2 diabetes and clear-cell renal-cell carcinoma, and therapeutic indications. | Sci Rep | 2024 | 39160196 | PubTator, text mining | PubMed |
| Exploring the interplay of English academic reading and writing proficiency among international doctoral students. | Heliyon | 2024 | 39113990 | PubTator, text mining | PubMed |
| Current genomic deep learning models display decreased performance in cell type-specific accessible regions. | Genome Biol | 2024 | 39090688 | PubTator, text mining | PubMed |
| Retraction of: Long noncoding RNA NR2F1-AS1 promotes the malignancy of non-small cell lung cancer via sponging microRNA-493-5p and thereby increasing ITGB1 expression. | Aging (Albany NY) | 2024 | 39084620 | PubTator, text mining | PubMed |
| Current genomic deep learning models display decreased performance in cell type specific accessible regions. | bioRxiv | 2024 | 39026761 | PubTator, text mining | PubMed |
| The short peptide encoded by long non-coding RNA RNF217-AS1 inhibits stomach cancer tumorigenesis, macrophage recruitment, and pro-inflammatory responses. | Amino Acids | 2024 | 39007996 | PubTator, text mining | PubMed |
| NR2F1 overexpression alleviates trophoblast cell dysfunction by inhibiting GDF15/MAPK axis in preeclampsia. | Hum Cell | 2024 | 39007956 | PubTator, text mining | PubMed |
| Genetic susceptibility to optic neuropathy in patients with alcohol use disorder. | J Transl Med | 2024 | 38796496 | PubTator, text mining | PubMed |
| Abscisic acid signaling through LANCL2 and PPARγ induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells. | Oncol Rep | 2024 | 38624012 | PubTator, text mining | PubMed |
| Proceedings of the CIMAGO Congress - Environment, Genetics and Oncobiology in the 21st Century - Challenges and Opportunities. | Medicine (Baltimore) | 2024 | 38579039 | PubTator, text mining | PubMed |
| Disrupted protein interaction dynamics in a genetic neurodevelopmental disorder revealed by structural bioinformatics and genetic code expansion. | Protein Sci | 2024 | 38511490 | PubTator, text mining | PubMed |
| PTEN decreases NR2F1 expression to inhibit ciliogenesis during EGFRL858R-induced lung cancer progression. | Cell Death Dis | 2024 | 38499532 | PubTator, text mining | PubMed |
| Epigenetic Switches in Retinal Homeostasis and Target for Drug Development. | Int J Mol Sci | 2024 | 38474086 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7025/papers?page=4